Rayonier Advanced Materials (RYAM) VP updates shareholdings after RSU conversion

Rhea-AI Filing Summary

Rayonier Advanced Materials reported an insider equity transaction by its Vice President of Manufacturing. On 04/10/2025, restricted stock units covering 26,270 shares of common stock were converted into shares at an exercise price of $0.0000, increasing the officer’s direct ownership.

On the same date, the insider disposed of 6,397 shares of common stock in a transaction coded "F" at a price of $4.76 per share, a form code typically used for shares withheld to cover taxes on vesting. After these transactions, the officer directly owned 39,746 shares of RYAM common stock. The filing notes that each restricted stock unit represents a contingent right to receive one share of common stock and that the original grant was scheduled to vest in two equal annual installments, subject to continued employment.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Osborne Michael D

(Last) (First) (Middle)

1301 RIVERPLACE BOULEVARD

SUITE 2300

(Street)

JACKSONVILLE FL 32207

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
RAYONIER ADVANCED MATERIALS INC. [ RYAM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Vice President, Manufacturing

3. Date of Earliest Transaction (Month/Day/Year)
04/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/10/2025		M		26,270	A	$0.0000	46,143	D
Common Stock	04/10/2025		F		6,397	D	$4.76	39,746	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	04/10/2025		M			26,270	(2)	04/10/2025	Common Stock	26,270	$0.0000	0.0000	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of RYAM common stock.

2. Grant of restricted stock units to vest 50% on the first anniversary of the grant date and 50% on the second anniversary of the grant date, assuming continued employment with the issuer.

	Brenda K. Davis, Attorney-in-Fact	12/05/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did RYAM report in this Form 4?

RYAM reported that its Vice President of Manufacturing converted 26,270 restricted stock units into common shares on 04/10/2025 and disposed of some shares the same day.

How many Rayonier Advanced Materials (RYAM) shares were sold in the transaction?

The insider disposed of 6,397 shares of RYAM common stock in a transaction coded "F" at $4.76 per share on 04/10/2025.

How many RYAM shares does the reporting person own after the transaction?

Following the reported transactions, the officer directly owned 39,746 shares of Rayonier Advanced Materials common stock.

What do the restricted stock units (RSUs) represent for RYAM?

Each restricted stock unit represents a contingent right to receive one share of RYAM common stock, as stated in the explanation of responses.

What was the vesting schedule for the RYAM restricted stock units?

The RSU grant was scheduled to vest 50% on the first anniversary of the grant date and 50% on the second anniversary, assuming continued employment with the company.

Who signed the RYAM Form 4 for this insider transaction?

The Form 4 was signed by Brenda K. Davis as Attorney-in-Fact on 12/05/2025.